China National Medicines Corporation Ltd.
600511
Hisse Senetlerindeki Sıralama
#4963
China National Medicines Corporation Ltd., in conjunction with its various... China National Medicines Corporation Ltd., in conjunction with its various operating entities, is a prominent player in the distribution of pharmaceutical goods across China. The enterprise's scope extends to the production and commercialization of innovative as well as pre-existing drug formulations. Additionally, it markets both traditional Chinese patent remedies and modern Western medications, alongside a range of medical apparatus. Complementing these activities, the firm delivers warehousing solutions and acts as an agent for import and export transactions. Its diverse clientele encompasses hospitals, retail pharmacies, and other healthcare organizations. Established in 1999, the company maintains its principal office in Beijing, China.
Hisse Fiyatı
$3.90
Son senkronizasyon: 2026-10-20
Piyasa Değeri
$2.94B
Değişim (1 gün)
-1.46%
Değişim (1 yıl)
-3.59%
Ülke
CN
Ticaret China National Medicines Corporation Ltd. (600511)
Kategori
Healthcare
China National Medicines Corporation Ltd. (600511) için gelir
Jun 2026 itibarıyla gelir TTM: $7.76B
China National Medicines Corporation Ltd. şirketinin en son finansal raporlarına göre, mevcut geliri (TTM) $7.76B'dir. 2023 yılında şirketin geliri $7.02B önceki yıla göre artış 2022 yılındaki $6.60B gelirine göre. Gelir, bir şirketin mal veya hizmet satışından elde ettiği toplam tutardır. Kazançtan farklı olarak, hiçbir gider düşülmez.
China National Medicines Corporation Ltd. için 2000 ile 2026 arasındaki gelir geçmişi
Her yılın sonunda gelir
| Yıl | Gelir | Değiştir |
|---|---|---|
| 2026 (TTM) | $7.76B | 11.97% |
| 2024 | $6.93B | -1.26% |
| 2023 | $7.02B | 6.44% |
| 2022 | $6.60B | -9.78% |
| 2021 | $7.31B | 18.28% |
| 2020 | $6.18B | -3.59% |
| 2019 | $6.41B | 13.84% |
| 2018 | $5.63B | 0.99% |
| 2017 | $5.58B | 11.87% |
| 2016 | $4.99B | 168.02% |
| 2015 | $1.86B | -0.15% |
| 2014 | $1.86B | 12.08% |
| 2013 | $1.66B | 20.63% |
| 2012 | $1.38B | 23.34% |
| 2011 | $1.12B | 24.59% |
| 2010 | $896.61M | 17.84% |
| 2009 | $760.87M | 18.39% |
| 2008 | $642.69M | 31.31% |
| 2007 | $489.45M | 36.11% |
| 2006 | $359.59M | 24.36% |
| 2005 | $289.14M | 32.86% |
| 2004 | $217.63M | 22.35% |
| 2003 | $177.87M | 20.30% |
| 2002 | $147.86M | 0.22% |
| 2001 | $147.54M | 11.05% |
| 2000 | $132.86M | 0.00% |
Benzer şirketler veya rakiplerin geliri
| Şirket | Gelir | Gelir Farkı | Ülke |
|---|---|---|---|
| $410.98B | 5,194.83% |
US
|
|
| - | - |
US
|
|
| $254.25B | 3,175.56% |
US
|
|
| - | - |
US
|
|
| $7.64B | -1.55% |
AU
|
